2 Dirt Cheap Dividend Stocks to Buy Right Now
Equity markets can be volatile, erratic, and not always entirely rational. That sometimes results in shares of companies not being adequately priced. And when these stocks trade for less than they're worth, it creates a perfect opportunity for investors to acquire them at a discount.
If you're looking for corporations that seem attractively valued right now, here are two that fit the bill: Bristol Myers Squibb (NYSE: BMY) and (NYSE: PFE). These two healthcare giants are excellent dividend stocks, too. Let's dig in.
Over the past year, Bristol Myers Squibb has lagged the stock market. One factor behind the company's poor performance is its slow, sometimes nonexistent, revenue growth throughout the past few quarters. Bristol Myers lost patent exclusivity for one of its formerly best-selling medicines early last year, which explains the struggling top line.
Source Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 41 € für Pfizer Inc. weist auf eine Steigerung von über 50% gegenüber dem aktuellen Kurs von 26.07 € hin.
